Evidence map›Paper›PMID 41059450›Full record

ArticleMolecular syndromology2025

Homozygous PGAP2 Mutation Causes Hyperphosphatasia with Mental Retardation Syndrome-3: Genetic and Clinical Evaluation of the Ultra-Rare Inherited Glycosylphosphatidylinositol Biosynthesis Defect.

Aynur Küçükçongar Yavaş, Sümeyra Zeynep Özbey, Bora Ergin, Yasemin Ünal, Berrak Bilginer Gürbüz, Betül Karaatmaca, Hamit Özyürek, Ofcan Oflaz, Hacer Basan, Çiğdem Seher Kasapkara

Abstract read
In one paragraph

Article in Molecular syndromology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aynur Küçükçongar YavaşDepartment of Pediatric Metabolism, Ankara Bilkent City Hospital, Ankara, Turkey.
Sümeyra Zeynep ÖzbeyDepartment of Pediatric Metabolism, Ankara Bilkent City Hospital, Ankara, Turkey.
Bora Erginİntergen Medical Genetic Center, Ankara, Turkey.
Yasemin ÜnalDepartment of Pediatric, Ankara Bilkent City Hospital, Ankara, Turkey.
Berrak Bilginer GürbüzDepartment of Pediatric Metabolism, Ankara Bilkent City Hospital, Ankara, Turkey.
Betül KaraatmacaDepartment of Pediatric Immunology, Ankara Bilkent City Hospital, Ankara, Turkey.
Hamit ÖzyürekDepartment of Pediatric Neurology, Ankara Bilkent City Hospital, Ankara, Turkey.
Ofcan OflazDepartment of Biochemistry, Lokman Hekim University, Ankara, Turkey.
Hacer BasanDepartment of Pediatric Metabolism, Ankara Bilkent City Hospital, Ankara, Turkey.
Çiğdem Seher KasapkaraDepartment of Pediatric Metabolism, Ankara Bilkent City Hospital, Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Inherited glycosylphosphatidylinositol biosynthesis defect is considered a subset of the congenital glycosylation disorder that results from mutations in the genes encoding proteins participating in glycosylphosphatidylinositol biosynthesis and modification. Glycosylphosphatidylinositol anchor proteins play important roles in numerous cellular processes including neurogenesis, cell adhesion, immune response, and signaling. Hyperphosphatasia with mental retardation syndrome-3 is one of the glycosylphosphatidylinositol anchor defects, characterized by moderate to severe intellectual disability, dysmorphic features, hypotonia, seizures, and persistent hyperphosphatasia. The aims of this study were to investigate the clinical implications of the Case Presentation: A male patient with dysmorphic features, neurodevelopmental delay, seizures, hearing loss, Hirschsprung disease, central fever, and elevated alkaline phosphatase was included in the study. The magnetic resonance imaging showed cerebral atrophy and corpus callosum hypoplasia. The whole-exome sequencing analysis of the individual and Sanger sequencing were performed for segregation. Additionally, next-generation sequencing, whole transcriptome sequencing, and homology modeling and analysis were performed. Whole-exome sequencing revealed a homozygous c.651C>G (p.His217Gln) in the Discussion: Homozygous PGAP2 mutations in the patient we reported in our study resulted in a severe clinical picture including severe developmental delay and intellectual disability, severe epilepsy, dysmorphic features, central fever, biochemical, hormonal, and immunological abnormalities. This patient would be the youngest case published in the literature. We showed that the instability of mutant PGAP2 protein that causes hyperphosphatasia with mental retardation syndrome-3 leads to more severe phenotypes.

Indexed as

Developmental delayGlycosylphosphatidylinositol-congenital disorder of glycosylationHyperphosphatasiaHyperphosphatasia mental retardation syndrome-3PGAP2 mutation

Identifiers

PMID41059450
PMCPMC12500300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.